Filter
2532
Filtered Results: 2532
Text search:
medical
laboratories
Featured
Recommendations
282
New Publications
717
Language
Document type
No document type
1404
Guidelines
420
Studies & Reports
340
Strategic & Response Plan
132
Manuals
130
Fact sheets
34
Situation Updates
31
Training Material
25
Brochures
7
Infographics
5
Resource Platforms
4
Countries / Regions
India
132
Congo, Democratic Republic of
96
Senegal
85
Sierra Leone
65
Kenya
64
Burkina Faso
59
Liberia
59
Western and Central Europe
56
Nigeria
53
Africa
53
Global
51
South Africa
51
Guinea
48
Ethiopia
46
Uganda
40
Rwanda
39
Benin
37
Nepal
34
Ghana
33
Haiti
32
Tanzania
30
West and Central Africa
30
Bangladesh
28
Eastern Europe
28
Latin America and the Carribbean
26
Cameroon
25
Zambia
25
Malawi
24
Syria
22
Côte d’Ivoire / Ivory Coast
22
East and Southern Africa
21
Mali
21
Ukraine
19
Philippines
19
Namibia
18
Myanmar / Burma
17
South–East Asia Region
16
Zimbabwe
15
Mozambique
15
Cambodia
15
Madagascar
14
Middle East and North Africa
11
Chad
11
Brazil
10
Yemen
10
Pakistan
10
Togo
9
Niger
9
Russia
9
Botswana
9
Eswatini/ Swaziland
9
Venezuela
8
Central African Republic
8
Colombia
7
Lesotho
7
USA
7
Asia
6
Western Pacific Region
6
South Sudan
6
Thailand
5
Albania
5
Afghanistan
5
Germany
5
Eastern Europe and Central Asia
5
Moldova
5
Georgia
5
Angola
5
Indonesia
5
Peru
4
Vietnam
4
Iraq
4
Somalia
4
Tajikistan
3
Turkey
3
China
3
Chile
3
Iran
3
Laos
3
Morocco
3
Saudi Arabia
3
France
3
Bolivia
3
Lebanon
3
North Macedonia
2
Timor Leste/ East Timor
2
Canada
2
Burundi
2
Armenia
2
Guinea-Bissau
2
Jordan
2
Gabon
2
Mauritius
2
Tunisia
2
Spain
2
Southern Africa
2
Argentina
2
Sri Lanka
2
Sudan
2
Libya
2
Ecuador
2
Mexico
1
El Salvador
1
Serbia
1
Gambia
1
Fiji
1
Estonia
1
Congo-Brazzaville
1
Malaysia
1
Qatar
1
Bulgaria
1
Mauritania
1
Croatia
1
Hungary
1
Paraguay
1
Luxembourg
1
North America
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
United Kingdom
1
Portugal
1
Papua New Guinea
1
Djibouti
1
Romania
1
Slovakia
1
Greece
1
Palestine
1
Poland
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
1109
Clinical Guidelines
234
Key Resources
97
Pharmacy & Technologies
88
Public Health
85
Women & Child Health
59
Capacity Building
21
Toolboxes
COVID-19
276
TB
222
Rapid Response
184
AMR
165
Ebola
155
HIV
144
Pharmacy
80
NTDs
74
Mental Health
53
Caregiver
47
Planetary Health
34
Conflict
34
Cholera
27
Zika
26
Specific Hazards
24
Refugee
21
Polio
21
Natural Hazards
20
Disability
15
NCDs
15
Health Financing Toolbox
13
Global Health Education
10
Social Ethics
3
Health Financing
1
Typhoon
1
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union...
Toolkit regarding Zika Virus
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor...
